Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the South of Brazil-Reference-Cited by-同舟云学术

Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the South of Brazil

Published:2011-07-04 Issue:3 Volume:18 Page:e236-e240
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

DE BARROS M. F.,HERRERO J. C. M.,SELL A. M.,De MELO F. C.,BRAGA M. A.,PELISSARI C. B.,MACHADO J.,De SOUZA SCHILLER S.,De SOUZA HIRLE L.,VISENTAINER J. E. L.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2011.02604.x/fullpdf

Reference32 articles.

1. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis;White;Thromb Haemost,2001

2. Registry of inherited coagulopathies in Brazil: first report;Rezende;Haemophilia,2009

3. The epidemiology of inhibitors in haemophilia A: a systematic review;Wight;Haemophilia,2003

4. Management of factor VIII inhibitors;Dimichele;Int J Hematol,2006

5. How we treat a haemophilia A patient with a factor VIII inhibitor;Kempton;Blood,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies;Journal of Pharmaceutical Sciences;2023-09

2. Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research Repository;Frontiers in Medicine;2022-06-23

3. Genetic Risk Factors for Inhibitor Development in Hemophilia A;Russian Journal of Genetics;2021-08

4. HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset;Frontiers in Medicine;2021-05-07

5. HLA-DRB1*01:01, but not HLA-DRB1:1503 or HLA-DRB1*11, is associated with decreased inhibitor risk in Iranian hemophilia A patients;Transfusion and Apheresis Science;2019-10